zidovudine has been researched along with Acute Hepatic Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Liu, L; Liu, XD; Miao, MX; Sun, BB; Tang, XG; Wang, F; Wang, ZJ; Zhao, KJ | 1 |
| Dhillon, AP; Lee, CA; Mistry, PK; Nitu, IC | 1 |
2 other study(ies) available for zidovudine and Acute Hepatic Failure
| Article | Year |
|---|---|
Acute liver failure enhances oral plasma exposure of zidovudine in rats by downregulation of hepatic UGT2B7 and intestinal P-gp.
Topics: Administration, Intravenous; Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Disease Models, Animal; Glucuronosyltransferase; Intestinal Absorption; Jejunum; Liver; Liver Failure, Acute; Male; Microsomes, Liver; Rats, Sprague-Dawley; Renal Elimination; Reverse Transcriptase Inhibitors; Thioacetamide; Zidovudine | 2017 |
Management of liver failure in a haemophilic patient co-infected with human immunodeficiency and hepatitis C viruses.
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Clarithromycin; Didanosine; Hemophilia A; Hepacivirus; Hepatitis C; HIV Infections; Humans; Liver Failure, Acute; Male; Middle Aged; Zidovudine | 1999 |